期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

前列腺癌放射性粒子近距治疗 被引量：3

原文传递
导出
摘要 前列腺癌（prostate cancer，PCa）放射性粒子近距治疗近年在国外发展迅速，因方法简便、疗效显著，已成为治疗早期PCa的一种行之有效的选择。
作者 宋刚 周利群 那彦群
机构地区 北京大学第一医院泌尿外科北京大学泌尿外科研究所
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2007年第4期285-287,共3页 Chinese Journal of Urology
关键词 放射性粒子 近距治疗 前列腺癌 治疗早期 PCa
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献27

  • 1Nag S,Beyer D,Friedland J,et al. American Brachytherapy Society (ABS)re-commendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys,1999,44:789-799.
  • 2Ragde H, Grado GL, Nadir B, et al.Mo-dern prostate brachytherapy. CA Cancer J Clin, 2000,50: 380-393.
  • 3Ove R, Wallner K, Badiozamani K, et al. Standardization of prostate brachy-therapy treatment plans. Int J Radiat Oncol Biol Phys, 2001,50 : 257-263.
  • 4Consensus statement: guidelines for PSA following radiation therapy. A-merican Society for Therapeutic Radiology and Oncology Consensus Panel.Int J Radiat Oncol Biol Phys, 1997,37:1035-1041.
  • 5Cavanagh W,Blasko JC,Grimm PD,et al. Transient elevation of serum prostate-specific antigen following (125) I/(103) Pd brachytherapy for localized prostate cancer. Semin Urol Oncol,2000,18:160-165.
  • 6Potters L, Morgenstern C, Calugaru E, et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol,2005,173:1562-1566.
  • 7王国民,徐志兵,朱延军,徐叶青,陈绍亮,曾昭冲,程文英.^(125)I放射性粒子永久植入治疗前列腺癌[J].中华泌尿外科杂志,2005,26(4):263-266. 被引量：18
  • 8黄毅,马潞林,王俊杰,冉维强.^(125)I放射粒子植入治疗激素难治性前列腺癌[J].中华泌尿外科杂志,2004,25(10):701-703. 被引量：18
  • 9D'Amico AV, Whittington R, Malkowicz SB,et al. Biochemical outcome after radical prostatectomy, external beamradiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, 1998, 280:969-974.
  • 10Sharkey J, Cantor A, Solc Z, et al. ^103 Pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer:a 12-year experience from a single group practice.Brachytherapy, 2005,4 : 34-44.

二级参考文献21

  • 1Holm HH, Stroyer I, Hansen H, et al. Ultrasonically guided percutaneous interstitial implantation of iodine 125 seeds in cancer therapy.Br J Radiol,1981,54 :665.
  • 2Ragde H ,Grado GL,Nadir BS. Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone.Arch Esp Urol,2001,54:739-747.
  • 3Sharkey, Cantor A, Solc Z, et al. Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer. Curr Urol Rep ,2002,3:250-257.
  • 4Anonymous. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys, 1997,37 :1035-1041.
  • 5Iannuzzi CM,Stock RG,Stone NN. PSA kinetics following 1-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer. Radiat Oneol Investig, 1999,7:30-35.
  • 6Chauveinc L, Flare T, Solignac S, et al. Indications for curietherapy of the prostate using permanent implants. Cancer Radiothcr, 2002,6 :154-158.
  • 7Kucway R,Vicini F, Huang R, et al. Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol,2002 ,167 :2443-2447.
  • 8Kleinberg L, Wallner K, Roy J, et al. Treatment- related symptoms during the first year following transperineal I- 125 prostate implantation. Int J Radiat Oncol Biol Phys, 1994,28:985-990.
  • 9Wallner K, Boy J, Harrison L. Low risk of perioperative infection without prophylactic for transperineal prostate brachytherapy. Int J Badiat Oncol Biol Phys, 1996,36:681-683.
  • 10Tapen EM, Blasko JC, Grimm PD, et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oneol Biol Phys,1998,42:1063-1067.

共引文献32

同被引文献50

  • 1陈昭典.前列腺特异性抗原在前列腺癌早期诊断中的价值[J].临床外科杂志,2004,12(2):72-73. 被引量：8
  • 2Schroder FH,Habbema DF,Roobol MJ,et al.Prostate cancer in the Swedish section of ERSPC-evidence for less metastases at diagnosis but not for mortality reduction.Eur Urol,2007,51:588-590.
  • 3叶敏.精益求精;进一步提高我国前列腺癌的诊治水平[J].中华泌尿外科杂志,2008,29:145-152.
  • 4Etzioni R,Gulati R,Falcon S,et al.Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States:a surveillance modeling approach.Med Decis Making,2008,28:323-331.
  • 5Lilja H,Ulmert D,Bjork T,et al.Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.J Clin Oncol,2007,25:431-436.
  • 6Korfage IJ,de Koning HJ.Habbema JD,et al.Side-effects of treatment for localized prostate cancer:are they valued differently by patients and healthy controls?BJU Int,2007,99:801-806.
  • 7Schroder FH.Biomarkers and screening for prostate cancer.Ann Oncol,2006,17:201-206.
  • 8Pelzer AE,Colleselli D,Bektic J,et al.Clinical and pathological features of screen vs non-screen-detected prostate cancers:is there a difference?BJU Int,2008,102:24-27.
  • 9Antenor JA,Roehl KA,Eggener SE,et al.Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease.Urology,2005,66:156-160.
  • 10Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008.CA Csneer J Clin,2008,58:71-96.

引证文献3

二级引证文献24

中华泌尿外科杂志
2007年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部